Bone Marrow Aspirate Concentrate (BMAC) therapy(Cell Technologies)

N/A

Report date: 2024/02/06 20:00:33

Base Information

Drug NameBone Marrow Aspirate Concentrate (BMAC) therapy(Cell Technologies)
Drug Alias NameAutologous Bone Marrow Aspirate Concentrate therapy(Cell Technologies)
ClassificationBiologics > Blood components
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsOsteoarthritis, KneeMusculoskeletal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesCell Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesCell Technologies Inc
Inactive CompaniesN/A
Active IndicationsOsteoarthritis, Knee
Inactive IndicationsMusculoskeletal Diseases

Other Information

ATC CodeN/A
Related LinksN/A